Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

Yujeong Kim, Hye Young Kwon, Brian Godman, Evelien Moorkens, Steven Simoens, Seung Jin Bae

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?'. Together they form a unique fingerprint.

Agricultural and Biological Sciences